文献速递认知障碍与痴呆

维生素B12状态标志物与阿尔茨海默病脑脊液生物标志物及认知表现的关系

Markers of Vitamin B12 Status in Relation to Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Cognitive Performance.
PubMed 文献 · Ann Neurol · 2023-05-23

研究纳入德国乌尔姆大学医院记忆门诊462例40至94岁患者,检测维生素B12、全转运钴胺素、同型半胱氨酸和甲基丙二酸,其中227例评估脑脊液Aβ42和总tau。多因素校正模型中,甲基丙二酸最高四分位与最低四分位相比,脑脊液总tau升高的OR为3.25(95%CI=1.35-7.76);第三四分位与最低四分位相比,Aβ42降低的OR为3.06(95%CI=1.22-7.67)。除维生素B12本身外,其他B12指标与情景记忆和执行功能等多个认知域相关。

要点

  • 甲基丙二酸最高四分位较低四分位者脑脊液总tau升高,OR=3.25(95%CI=1.35-7.76)。
  • 甲基丙二酸第三四分位较低四分位者脑脊液Aβ42降低,OR=3.06(95%CI=1.22-7.67)。
  • 除维生素B12本身外,其他B12指标与情景记忆和执行功能等认知域相关。

核心结论

  • 维生素B12标志物可能是阿尔茨海默病脑脊液生物标志物和认知功能的独立预测因素,其中甲基丙二酸效应最一致。
  • 需要随机对照试验确定补充维生素B12对延缓脑结构改变和认知下降的重要性。

研究设计与样本

  • 研究纳入德国乌尔姆大学医院记忆门诊462例40至94岁患者。
  • 检测维生素B12、全转运钴胺素、同型半胱氨酸和甲基丙二酸。
  • 227例参与者评估脑脊液淀粉样蛋白β42和总tau。
  • 使用CERAD battery评估认知状态并衍生不同认知域。
  • 采用回归模型研究关联。

主要发现

  • 多因素校正模型中,甲基丙二酸最高四分位与最低四分位相比,脑脊液总tau升高的OR为3.25(95%CI=1.35-7.76)。
  • 甲基丙二酸第三四分位与最低四分位相比,Aβ42降低的OR为3.06(95%CI=1.22-7.67)。
  • 除维生素B12本身外,所有B12指标与情景记忆和执行功能等多个认知域相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association between markers of vitamin B12 status and cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD), which precede cognitive impairment, has been investigated by only a few small studies and results have been inconsistent. AIM: The aim of this study was to investigate the associations of vitamin B12-related markers with CSF biomarkers of AD and cognitive performance. METHODS: Data included 462 patients aged 40 to 94 years referred to the Memory Clinic of the Ulm University Hospital, Ulm, Germany. Vitamin B12, holotranscobalamin (HoloTC), homocysteine (tHcy), and methylmalonic acid (MMA) have been measured. CSF values of amyloid β42 (Aβ42 ) and total-tau have been assessed in 227 participants. CERAD battery was administered to examine the cognitive status, and different domains were derived. Regression models were used to investigate the associations. RESULTS: In the multi-adjusted model, higher levels of MMA were associated with raised CSF total-tau values: the odds ratios (ORs) 95% confidence intervals (CIs) were 3.25 (95% CI = 1.35-7.76) for the highest quartile of MMA compared to the lowest. Furthermore, moderately increased MMA were related to lower Aβ42 levels: the ORs and 95% CIs were 3.06 (95% CI = 1.22-7.67) for the third quartile of MMA compared to the lowest. All B12 indicators except B12 itself were related to several cognitive domains, such as episodic memory and executive functioning. CONCLUSIONS: Markers of vitamin B12 may be independent predictors of CSF biomarkers of AD and cognitive functioning, with MMA showing the most consistent effects. Randomized controlled trials are needed to determine the importance of vitamin B12 supplementation on slowing structural brain changes and cognitive decline. ANN NEUROL 2023;94:223-231.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Hooshmand B, Appold F, Fissler P, et al. Markers of Vitamin B12 Status in Relation to Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Cognitive Performance. Ann Neurol. 2023. PMID: 37177814. doi:10.1002/ana.26673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。